Preliminary research suggest conolidine may inhibit certain ion channels, decreasing neuronal excitability and limiting suffering indicators. This system is particularly relevant in neuropathic discomfort, in which irregular signaling results in persistent irritation. Additionally, conolidine appears to impact G protein-coupled receptor (GPCR) pathways integral to suffering perception... https://carlr370wsn9.homewikia.com/user